AMIX
Autonomix is a medical technology company developing a first-in-class platform to map and ablate nerves through transvascular approaches. Its technology aims to provide real-time intra-procedural nerve mapping and targeted denervation, enabling precision therapy across interventional pain, cardiology, pulmonology, and gastroenterology. Headquartered in The Woodlands, Texas, the company emphasizes a growing global IP portfolio with potential applications in a range of nervous-system–related diseases.
No recent news for this company.
No recent deals for this company.